Harvey E. Behrend

Array ( [id] => 4183568 [patent_doc_number] => 06020381 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-01 [patent_title] => 'Use of 2-methylamino-2-phenylcyclohexanone for the treatment of protozoan infections' [patent_app_type] => 1 [patent_app_number] => 8/729962 [patent_app_country] => US [patent_app_date] => 1996-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2026 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/020/06020381.pdf [firstpage_image] =>[orig_patent_app_number] => 729962 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3950692 [patent_doc_number] => 05955508 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-21 [patent_title] => 'Method for the enhancement of lymphocyte activity against opportunistic microbial pathogens' [patent_app_type] => 1 [patent_app_number] => 8/729868 [patent_app_country] => US [patent_app_date] => 1996-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9836 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/955/05955508.pdf [firstpage_image] =>[orig_patent_app_number] => 729868 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4175458 [patent_doc_number] => 06083992 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-04 [patent_title] => 'Use of 2-methylamino-2-phenylcyclohexanone for the treatment of bacterial infections' [patent_app_type] => 1 [patent_app_number] => 8/732525 [patent_app_country] => US [patent_app_date] => 1996-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1526 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/083/06083992.pdf [firstpage_image] =>[orig_patent_app_number] => 732525 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4261578 [patent_doc_number] => 06258847 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-10 [patent_title] => 'Use of 2-mercaptoethanolamine (2-MEA) and related aminothiol compounds and copper(II)-3,5 di-isopropyl salicylates and related compounds in the prevention and treatment of various diseases' [patent_app_type] => 1 [patent_app_number] => 8/719908 [patent_app_country] => US [patent_app_date] => 1996-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12461 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/258/06258847.pdf [firstpage_image] =>[orig_patent_app_number] => 719908 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4046180 [patent_doc_number] => 05908857 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-01 [patent_title] => 'Agent for the treatment of infections' [patent_app_type] => 1 [patent_app_number] => 8/704673 [patent_app_country] => US [patent_app_date] => 1996-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7421 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 357 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/908/05908857.pdf [firstpage_image] =>[orig_patent_app_number] => 704673 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4048637 [patent_doc_number] => 05869511 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-09 [patent_title] => 'Isoxazoline compounds as inhibitors of TNF release' [patent_app_type] => 1 [patent_app_number] => 8/700431 [patent_app_country] => US [patent_app_date] => 1996-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11609 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 615 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/869/05869511.pdf [firstpage_image] =>[orig_patent_app_number] => 700431 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4305510 [patent_doc_number] => 06326383 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-04 [patent_title] => 'Medical use for tachykinin antagonists' [patent_app_type] => 1 [patent_app_number] => 8/706836 [patent_app_country] => US [patent_app_date] => 1996-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10495 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/326/06326383.pdf [firstpage_image] =>[orig_patent_app_number] => 706836 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3966747 [patent_doc_number] => 05886000 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-23 [patent_title] => 'Anti-HIV agent' [patent_app_type] => 1 [patent_app_number] => 8/676224 [patent_app_country] => US [patent_app_date] => 1996-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 2580 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/886/05886000.pdf [firstpage_image] =>[orig_patent_app_number] => 676224 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4234475 [patent_doc_number] => 06117844 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-12 [patent_title] => 'Method and composition for antiviral therapy' [patent_app_type] => 1 [patent_app_number] => 8/668324 [patent_app_country] => US [patent_app_date] => 1996-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3338 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/117/06117844.pdf [firstpage_image] =>[orig_patent_app_number] => 668324 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4327103 [patent_doc_number] => 06329394 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-11 [patent_title] => 'Medical use for tachykinin antagonists' [patent_app_type] => 1 [patent_app_number] => 8/670021 [patent_app_country] => US [patent_app_date] => 1996-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12105 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/329/06329394.pdf [firstpage_image] =>[orig_patent_app_number] => 670021 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4103021 [patent_doc_number] => 06022545 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-08 [patent_title] => 'Usage of pathogen-killing foams' [patent_app_type] => 1 [patent_app_number] => 8/668407 [patent_app_country] => US [patent_app_date] => 1996-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1429 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/022/06022545.pdf [firstpage_image] =>[orig_patent_app_number] => 668407 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4066077 [patent_doc_number] => 06008228 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-28 [patent_title] => 'Pharmaceutical compositions containing proteinase inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/616233 [patent_app_country] => US [patent_app_date] => 1996-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11596 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/008/06008228.pdf [firstpage_image] =>[orig_patent_app_number] => 616233 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4014170 [patent_doc_number] => 05880124 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-09 [patent_title] => 'Blocking induction of tetrahydrobiopterin to block induction of nitric oxide synthesis' [patent_app_type] => 1 [patent_app_number] => 8/642883 [patent_app_country] => US [patent_app_date] => 1996-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8592 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/880/05880124.pdf [firstpage_image] =>[orig_patent_app_number] => 642883 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3828786 [patent_doc_number] => 05760065 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-02 [patent_title] => 'Anti-HIV agent' [patent_app_type] => 1 [patent_app_number] => 8/640741 [patent_app_country] => US [patent_app_date] => 1996-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1739 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/760/05760065.pdf [firstpage_image] =>[orig_patent_app_number] => 640741 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3771303 [patent_doc_number] => 05849786 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-15 [patent_title] => 'Process for the treatment or prevention of herpes' [patent_app_type] => 1 [patent_app_number] => 8/632420 [patent_app_country] => US [patent_app_date] => 1996-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1822 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/849/05849786.pdf [firstpage_image] =>[orig_patent_app_number] => 632420 [rel_patent_id] =>[rel_patent_doc_number] =>)